ModernVivo
ModernVivo provides a literature intelligence platform for researchers in drug discovery and development. Its product analyzes millions of peer-reviewed publications to help users identify relevant in vivo models, extract detailed protocol conditions, and cross-reference data with clinical trial and regulatory guidance. The platform aims to accelerate and improve study design for scientists in industry and academia.
Facts
- HQ
- Seattle
- Sectors
- Software Development
- Founded
- 2023
- Type
- Corporation Seattle business license
- Employees
- 6
- Registered name
- ModernVivo Inc Seattle business license
- Stage
- PreSeed
Is this your organization? Claim it
Ian Levine says ModernVivo launched with little startup network, credits University of Michigan mentors and investors for key support
Ian Levine describes founding ModernVivo with little startup network, crediting the University of Michigan ecosystem and mentors for guidance, and emphasizes paying that generosity forward to help founders without networks.
ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes
ModernVivo, a Seattle startup, uses AI to scan millions of published animal studies and related data to help researchers design preclinical drug experiments faster, reducing literature review time from weeks to minutes and aiming to improve experiment quality while using fewer animals.
ModernVivo launches ModernVivo Marketplace on Sept. 15, 2026 to connect preclinical teams with pre-vetted CROs
ModernVivo announced on Sept. 15, 2026 the launch of ModernVivo Marketplace, a service to help preclinical R&D teams find pre-vetted CROs faster for in vivo study design and execution.
See all 7 stories, episodes and videos about ModernVivo.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Ian Levine Co-Founder and CEO